Sector Public Health, Social Development & Labour (VSA) Inspection Pharmaceutical Department, is calling on the population who have obtained Tylenol and Benadryl medicine from establishments other than the local pharmacies, to stop usage immediately.
McNeil Consumer Healthcare (Johnson & Johnson) has expanded a January 15, 2010 recall to include certain Tylenol and Benadryl products.
The local supplier of Tylenol and Benadryl on the island never received the lot of contaminated products in question; however Inspection VSA Pharmaceutical Department is taking this proactive measure to ensure public safety.
The expansion involves four product lots of BENADRYL® ALLERGY ULTRATAB™ TABLETS, 100 (Lot Nos. AJA008, ADA194, ABA022 and ABA264) sold in the United States and one product lot of EXTRA STRENGTH TYLENOL® Rapid Release Gels, 50 count (Lot No. ASA202) sold in the United States, Trinidad and Tobago, Bermuda and Puerto Rico.
The product lot numbers for the recalled products can be found on the side of the bottle label.
The original recall was initiated as a result of consumer complaints of a musty or mouldy odour that has since been linked to the presence of trace amounts of a chemical used to build wooden pallets that transport and store product packaging materials.
Persons can contact the Inspection VSA Pharmaceutical Department on 542-2059 for more information.